Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03173157 · ClinicalTrials.gov registry record · NA

Effect of Targeted Interventions to Improve Value Based Health Care for Inpatient Cardiology Patients

A NA study of Heart Failure and Heart Diseases, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
183
Enrollment target
1
Study location

NCT03173157 is a NA study of Heart Failure and Heart Diseases that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 183 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03173157, a NA study of Heart Failure and Heart Diseases, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
183 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that a combined didactic and data feedback program presenting evidence based indications and in-hospital-charges for echocardiograms to inpatient cardiology team members will lead to increased health care value for patients on inpatient cardiology teams.

Interventions

  • OTHER Value Feedback Email

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2017-02-27
Est. Completion 2017-12-31
Phase NA

What the Registry Record Tells You About NCT03173157

The ClinicalTrials.gov registry entry for NCT03173157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Value Feedback Email is the first listed.

NCT03173157 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03173157 about?

NCT03173157 is a clinical study titled "Effect of Targeted Interventions to Improve Value Based Health Care for Inpatient Cardiology Patients". The investigators hypothesize that a combined didactic and data feedback program presenting evidence based indications and in-hospital-charges for echocardiograms to inpatient cardiology team members will lead to increased health care value for patients on inpatient cardiology teams.

What is the current status of trial NCT03173157?

This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2017-02-27. Estimated completion is 2017-12-31.

What conditions does trial NCT03173157 study?

This clinical trial studies the following conditions: Heart Failure, Heart Diseases.

What interventions are being tested in trial NCT03173157?

The interventions under investigation include: Value Feedback Email (OTHER).

Who is sponsoring clinical trial NCT03173157?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03173157 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.